Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.  Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at and follow and on .
Summary of Position:
This is an exciting opportunity for a highly analytical and strategic individual to join our team as a Director/Sr. Director of Early Pipeline Commercialization. This role is critical in shaping the future success of our pipeline by providing market-driven insights to inform portfolio prioritization, indication selection, and strategic positioning. You will work cross-functionally with R&D, regulatory, corporate strategy and commercial teams to ensure seamless integration of scientific innovation with market needs. This is a high-impact, high-visibility role with a unique opportunity to lead in an entrepreneurial environment and affect the trajectory of the company’s first launch.Position Responsibilities: Portfolio Prioritization: Represent commercial perspective to inform portfolio prioritization and shape development strategy to optimize for commercial successStrategic Evaluation: Evaluate early pipeline opportunities together with Corporate Strategy team to define target product profile, value propositions and early positioningLandscape Assessments: Conduct in-depth market landscape analyses to understand disease areas, unmet needs, market opportunities, and evolving trends that can influence pipeline strategy.Competitive Intelligence: Gather and synthesize competitive intelligence, including benchmarking competitors’ pipelines, product launches, and clinical developments, to identify risks and opportunities.Market Research & Insights: Design and implement an aligned internal process along with overseeing primary and secondary market research projects to evaluate the commercial potential of pipeline assets and inform go/no-go decisions for indication prioritization.Indication Planning: Collaborate with corporate strategy, R&D and clinical development teams to identify and prioritize next indications, considering patient population, treatment paradigm, and competitive landscape.Cross-Functional Collaboration: Serve as the commercial voice on pipeline asset teams, working closely with R&D, corporate strategy, clinical development, regulatory, and finance to align on program strategy.Candidate Requirements:Bachelor's degree in life sciences, business, or related field; MBA, PharmD, or advanced degree preferred.A minimum of 5 years of experience in pharmaceutical/biotechnology strategy, new product planning, or commercialization.Strong knowledge of market research methodologies, competitive intelligence, and landscape evaluation.Exceptional analytical and problem-solving skills, with experience in strategic decision-making.Ability to work effectively collaborating across several functions.Excellent communication and presentation skills, with the ability to distill complex data into actionable insights.Preferred Experience:Experience in therapeutic areas of focus (e.g., oncology, rare diseases, neurology, etc.).Knowledge of regulatory and clinical development processes.Global market experience and understanding of market access and pricing dynamics.Competencies:Strategic mindset with a deep understanding of the product lifecycle.Proactive and adaptable in a fast-paced environment.High attention to detail and results-oriented.Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.